Skip to main content

Anti-Integrin alpha 5 beta 1 [IPI-ITGA5/ITGB1.2] in Flow Cytometry (Human)

Addgene #209611

Data Submitted By
IPI Staff
Lab Name
Institute for Protein Innovation (IPI)
Submission Date
March 20, 2024
Publication Date
March 25, 2024 (modified March 25, 2024)
Abstract
Experimental results for the human IgG1 isotype of the Anti-Integrin alpha 5 beta 1 [IPI-ITGA5/ITGB1.2] (Addgene Antibody 209611) in a flow cytometry assay with a human sample.
Caption: Histogram from FACS analysis on Expi293F α5-/αV- cells (blue) and Expi293F α5-/αV- transiently transfected cells expressing human RGD-binding integrins α5β1 (red). Cells were labeled with the human IgG1 isotype version of the IPI-ITGA5/ITGB1.2 antibody and APC-conjugated goat anti-human IgG secondary antibody.
Image attribution: Institute for Protein Innovation (IPI)

This report is made available under the Creative Commons Attribution 4.0 International License.

Antibodies Used
Anti-Integrin alpha 5 beta 1 [IPI-ITGA5/ITGB1.2]
Addgene #209611
APC-conjugated goat anti-human secondary antibodies
Jackson ImmunoResearch #109-135-098

Materials & Methods

Sample

Species
Human
Cell / Tissue Type
Expi293F α5-/αV- cells

Primary Antibody

Name
Anti-Integrin alpha 5 beta 1 [IPI-ITGA5/ITGB1.2]
Source
Addgene
Catalog Number
209611
Species
Rabbit
Gene / Target
ITGA5, ITGB1
Concentration
50 nM
Time
60 min
Temperature
4 °C
View in Addgene Catalog

Secondary Antibody

Name
APC-conjugated goat anti-human secondary antibodies
Source
Jackson ImmunoResearch
Catalog Number
109-135-098
Concentration
1:150
Time
60 min
Temperature
4 ˚C

Additional Information

Additional Information

NOTE: The data presented in this plot is for the human IgG1 isotype of this antibody.

The plasmids encoding full-length α5 and β1 subunits were transiently transfected into Expi293 α5-/αV- cells (Lin et al., 2022 (Link opens in a new window)) using FectoPro (Polyplus) according to the manufacturer’s instructions. The cells were cultured in Expi293 medium at 37 °C in an 8% CO2 incubator. After 24 hours of transfection, 3 mM valproic acid and 4 g/L of glucose were added. After 48 hours of transfection, transiently transfected cells were harvested and washed 3x in 1X Hanks' balanced salt solution (HBSS) with 20 mM HEPES pH 7.4, 1% BSA, 1 mM Ca2+, and 1 mM Mg2+ buffer (labeling buffer) to a final cell density of 1 x 106 cells/mL. In the last resuspension, each sample containing 1x105 cells was resuspended in 50 µL labeling buffer, and the IPI antibody was added to the desired labeling concentration.

Primary antibody: 50 nM in 1X HBSS with 20 mM HEPES pH 7.4, 1% BSA, 1 mM Ca2+, and 1 mM Mg2+ buffer, 60 min, 4 °C.

Secondary antibody: APC-conjugated goat anti-human secondary antibodies (Jackson ImmunoResearch, catalog 109-135-098, at 1:150 dilution) in 1X HBSS with 20 Mm HEPES pH 7.4, 1% BSA, 1 mM Ca2+, and 1 mM Mg2+ buffer, 30 min, 4 °C.

Detection: FACS was performed on a BD FACSCanto II. The background mean fluorescence intensity (MFI) was determined using a human IgG1 isotype control (Bioxcell #BE0297) at the same concentration as the primary antibodies. Washing steps were applied after addition of the primary and secondary antibody. Data analysis was performed with FlowJo (Version 10.7.1).

Results

Result
Pass (The antibody worked under these conditions)